2013 Q4 Form 10-K Financial Statement

#000114420414004909 Filed on January 30, 2014

View on sec.gov

Income Statement

Concept 2013 Q4 2013 2012 Q4
Revenue $7.230M $7.278M $0.00
YoY Change 38666.35% -100.0%
Cost Of Revenue $440.0K $461.7K $10.00K
YoY Change 4300.0% 579.26% -94.74%
Gross Profit $6.780M $6.817M $0.00
YoY Change -13957.36% -100.0%
Gross Profit Margin 93.78% 93.66%
Selling, General & Admin $650.0K $4.116M $490.0K
YoY Change 32.65% 81.52% 16.67%
% of Gross Profit 9.59% 60.38%
Research & Development $250.0K $744.2K $240.0K
YoY Change 4.17% 2.06% -59.32%
% of Gross Profit 3.69% 10.92%
Depreciation & Amortization -$30.00K $144.3K $200.0K
YoY Change -115.0% -27.86% 11.11%
% of Gross Profit -0.44% 2.12%
Operating Expenses $870.0K $5.004M $780.0K
YoY Change 11.54% 67.0% -26.42%
Operating Profit $5.910M $1.812M -$780.0K
YoY Change -857.69% -155.87% -38.58%
Interest Expense -$10.12M $748.6K -$3.520M
YoY Change 187.5% -121.45% -266.04%
% of Operating Profit -171.24% 41.3%
Other Income/Expense, Net -$3.610M -$27.97M
YoY Change 700.71%
Pretax Income -$7.820M -$26.15M -$4.310M
YoY Change 81.44% 288.03% -601.16%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income
Net Earnings -$7.820M -$26.15M -$4.300M
YoY Change 81.86% 288.3% -600.0%
Net Earnings / Revenue -108.16% -359.33%
Basic Earnings Per Share -$0.60
Diluted Earnings Per Share -$153.5K -$0.60 -$146.1K
COMMON SHARES
Basic Shares Outstanding 49.72M shares 43.64M shares 31.60M
Diluted Shares Outstanding

Balance Sheet

Concept 2013 Q4 2013 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $5.830M $5.830M $0.00
YoY Change -100.0%
Cash & Equivalents $5.831M
Short-Term Investments
Other Short-Term Assets $460.0K $460.0K $10.00K
YoY Change 4500.0% 4500.0% -50.0%
Inventory $1.406M $1.410M $1.231M
Prepaid Expenses $0.00 $10.04K
Receivables $0.00 $40.00K $40.00K
Other Receivables $10.00K $10.00K $0.00
Total Short-Term Assets $7.744M $7.740M $1.281M
YoY Change 504.39% 504.69% 31.92%
LONG-TERM ASSETS
Property, Plant & Equipment $2.998M $3.000M $6.030K
YoY Change 49614.1% 29900.0% -23.3%
Goodwill $0.00
YoY Change
Intangibles $1.545M $1.353M
YoY Change 14.16% -2.44%
Long-Term Investments $7.529M
YoY Change
Other Assets $1.545M $0.00 $0.00
YoY Change -100.0%
Total Long-Term Assets $1.545M $4.550M $1.358M
YoY Change 13.8% 234.56% -4.22%
TOTAL ASSETS
Total Short-Term Assets $7.744M $7.740M $1.281M
Total Long-Term Assets $1.545M $4.550M $1.358M
Total Assets $12.29M $12.29M $2.645M
YoY Change 364.55% 365.53% 10.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $54.67K $50.00K $1.411M
YoY Change -96.12% -96.45% 32.47%
Accrued Expenses $575.7K $580.0K $503.0K
YoY Change 14.46% 13.73% -10.35%
Deferred Revenue
YoY Change
Short-Term Debt $170.0K $170.0K $2.070M
YoY Change -91.79% -91.79% 152.44%
Long-Term Debt Due $0.00 $0.00 $620.0K
YoY Change -100.0% -100.0% 44.19%
Total Short-Term Liabilities $984.3K $980.0K $4.603M
YoY Change -78.62% -78.7% 60.17%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities $3.780M $3.780M $4.170M
YoY Change -9.35% -9.35% 658.18%
Total Long-Term Liabilities $3.780M $3.780M $4.170M
YoY Change -9.35% -9.35% 471.23%
TOTAL LIABILITIES
Total Short-Term Liabilities $984.3K $980.0K $4.603M
Total Long-Term Liabilities $3.780M $3.780M $4.170M
Total Liabilities $4.764M $4.760M $8.776M
YoY Change -45.72% -45.79% 143.73%
SHAREHOLDERS EQUITY
Retained Earnings -$39.93M -$13.78M
YoY Change 189.84% 95.65%
Common Stock $569.00 $344.00
YoY Change 65.41% 26.01%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $7.523M $7.520M -$6.131M
YoY Change
Total Liabilities & Shareholders Equity $12.29M $12.29M $2.645M
YoY Change 364.55% 365.53% 10.73%

Cashflow Statement

Concept 2013 Q4 2013 2012 Q4
OPERATING ACTIVITIES
Net Income -$7.820M -$26.15M -$4.300M
YoY Change 81.86% 288.3% -600.0%
Depreciation, Depletion And Amortization -$30.00K $144.3K $200.0K
YoY Change -115.0% -27.86% 11.11%
Cash From Operating Activities $6.280M $3.856M -$460.0K
YoY Change -1465.22% -318.53% -53.06%
INVESTING ACTIVITIES
Capital Expenditures -$680.0K $457.7K -$160.0K
YoY Change 325.0% -386.06% -72.88%
Acquisitions
YoY Change
Other Investing Activities -$2.970M -$2.990M $0.00
YoY Change -100.0%
Cash From Investing Activities -$3.650M -$3.743M -$160.0K
YoY Change 2181.25% 2199.38% 433.33%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 2.170M $5.717M 620.0K
YoY Change 250.0% 241.3% -50.4%
NET CHANGE
Cash From Operating Activities 6.280M $3.856M -460.0K
Cash From Investing Activities -3.650M -$3.743M -160.0K
Cash From Financing Activities 2.170M $5.717M 620.0K
Net Change In Cash 4.800M $5.830M 0.000
YoY Change -2413.1% -100.0%
FREE CASH FLOW
Cash From Operating Activities $6.280M $3.856M -$460.0K
Capital Expenditures -$680.0K $457.7K -$160.0K
Free Cash Flow $6.960M $3.398M -$300.0K
YoY Change -2420.0% -311.8% -23.08%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2012Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
0 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
10653469 shares
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1357536 USD
CY2012Q4 us-gaap Assets
Assets
2644871 USD
CY2012Q4 us-gaap Short Term Bank Loans And Notes Payable
ShortTermBankLoansAndNotesPayable
174925 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1410650 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3492588 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-27965605 USD
CY2012Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
1353304 USD
CY2012Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
4232 USD
CY2013Q4 us-gaap Deferred Finance Costs Noncurrent Net
DeferredFinanceCostsNoncurrentNet
0 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
1544869 USD
CY2012Q4 xxii Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
3567 USD
CY2013Q4 xxii Interest Payable Related Parties Current
InterestPayableRelatedPartiesCurrent
0 USD
CY2012Q4 us-gaap Notes Payable Current
NotesPayableCurrent
617000 USD
CY2013Q4 us-gaap Notes Payable Current
NotesPayableCurrent
0 USD
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1893804 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4602948 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
984334 USD
CY2012Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
4173140 USD
CY2013Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
3779522 USD
CY2012Q4 us-gaap Liabilities
Liabilities
8776088 USD
CY2013Q4 us-gaap Liabilities
Liabilities
4763856 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7645017 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
47452055 USD
CY2012Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-13776578 USD
CY2012Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-6131217 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2644871 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
344 USD
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
569 USD
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-39929736 USD
CY2013Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
7522888 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
12286744 USD
CY2011 xxii Volume Of Commodity Sold
VolumeOfCommoditySold
12000000 Number
CY2012 xxii Volume Of Commodity Sold
VolumeOfCommoditySold
12000000 Number
CY2012Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000 shares
CY2012Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000 shares
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00001
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34286979 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
56902770 shares
CY2013Q4 us-gaap Derivative Liabilities Current
DerivativeLiabilitiesCurrent
290000 USD
CY2013 xxii Warrants Issued During Period Value
WarrantsIssuedDuringPeriodValue
168402 USD
CY2012Q2 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
1710833 shares
CY2012Q2 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1710833 shares
CY2012Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
3238000 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34286979 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
56902770 shares
CY2013Q1 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
2035000 USD
CY2013Q2 us-gaap Dividends Payable Current
DividendsPayableCurrent
93361 USD
CY2013 xxii Increase Decrease In Capital
IncreaseDecreaseInCapital
204513 USD
CY2013Q3 xxii Stock Issued During Period Shares Warrant Exercised
StockIssuedDuringPeriodSharesWarrantExercised
1972976 shares
CY2013 xxii Adjustments To Additional Paid In Capital Accrued Dividend Payable
AdjustmentsToAdditionalPaidInCapitalAccruedDividendPayable
93361 USD
CY2013Q3 xxii Common Stock Issued Price Per Share
CommonStockIssuedPricePerShare
1.31
CY2013Q3 xxii Maximum Exposure Amount For Contingent Liability
MaximumExposureAmountForContingentLiability
1183333 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights
ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights
1619000 shares
CY2012Q2 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
1026500 USD
CY2012Q4 us-gaap Sale Of Stock Consideration Received Per Transaction
SaleOfStockConsiderationReceivedPerTransaction
809500 USD
CY2012Q2 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
786500 USD
CY2012Q4 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
681000 USD
CY2012Q2 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
150000 USD
CY2012Q4 us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
98500 USD
CY2012Q4 xxii Forgiveness Of Directors Fees
ForgivenessOfDirectorsFees
30000 USD
CY2012Q2 us-gaap Equity Method Investment Ownership Percentage
EquityMethodInvestmentOwnershipPercentage
0.04 pure
CY2012Q2 xxii Non Cash Equity Method Investments
NonCashEquityMethodInvestments
90000 USD
CY2012Q2 xxii Warrants Exercise Price
WarrantsExercisePrice
1.00
CY2012Q4 xxii Warrants Exercise Price
WarrantsExercisePrice
1.00
CY2012Q2 xxii Issuance Of Warrant Value
IssuanceOfWarrantValue
1841000 USD
CY2012Q4 xxii Issuance Of Warrant Value
IssuanceOfWarrantValue
353747 USD
CY2012Q2 xxii Non Cash Consideration Expense
NonCashConsiderationExpense
814500 USD
CY2012 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075 pure
CY2013 us-gaap Debt Instrument Basis Spread On Variable Rate1
DebtInstrumentBasisSpreadOnVariableRate1
0.0075 pure
CY2012Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0400 pure
CY2013Q4 us-gaap Debt Instrument Interest Rate Effective Percentage
DebtInstrumentInterestRateEffectivePercentage
0.0400 pure
CY2013 xxii Loan Repayment Terms Minimum
LoanRepaymentTermsMinimum
P30D
CY2012Q4 us-gaap Notes Payable
NotesPayable
617000 USD
CY2013Q4 us-gaap Notes Payable
NotesPayable
0 USD
CY2013Q1 us-gaap Accounts Payable Current And Noncurrent
AccountsPayableCurrentAndNoncurrent
67704 USD
CY2013Q4 us-gaap Debt Instrument Periodic Payment Interest
DebtInstrumentPeriodicPaymentInterest
181233 USD
CY2013Q1 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
396750 USD
CY2013Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
1.00
CY2012Q3 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2013Q3 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2012Q4 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2011Q4 us-gaap Share Price
SharePrice
0.90
CY2012Q4 xxii Convertible Notes Face Amount
ConvertibleNotesFaceAmount
120750 USD
CY2013Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
222600 USD
CY2012Q4 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
55000 USD
CY2012 xxii Conversion Of Convertible Notes Shares Of Common Stock Per Convertible Note
ConversionOfConvertibleNotesSharesOfCommonStockPerConvertibleNote
161494 shares
CY2013Q3 xxii Conversion Of Convertible Notes Shares Of Common Stock Per Convertible Note
ConversionOfConvertibleNotesSharesOfCommonStockPerConvertibleNote
371000 shares
CY2012 xxii Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
193793 shares
CY2013Q3 xxii Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
371000 shares
CY2012Q4 xxii Unamortized Discount On Convertible Notes
UnamortizedDiscountOnConvertibleNotes
66000 USD
CY2012 xxii Warrant Liabilities Fair Value
WarrantLiabilitiesFairValue
152000 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
31000 USD
CY2012 xxii Amortization Of Convertible Debt Discount
AmortizationOfConvertibleDebtDiscount
1284363 USD
CY2012Q4 xxii Convertible Debt Fair Value
ConvertibleDebtFairValue
2028100 USD
CY2013Q4 xxii Convertible Debt Fair Value
ConvertibleDebtFairValue
0 USD
CY2011 us-gaap Finitelived Intangible Assets Acquired1
FinitelivedIntangibleAssetsAcquired1
22500 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
729225 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
744230 USD
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2205450 USD
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4106694 USD
CY2012 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
61876 USD
CY2013 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
9052 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
198406 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
144289 USD
CY2012 us-gaap Costs And Expenses
CostsAndExpenses
3194957 USD
CY2013 us-gaap Costs And Expenses
CostsAndExpenses
5004265 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-3244149 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
1812447 USD
CY2012 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-1998043 USD
CY2013 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-23602711 USD
CY2012 us-gaap Profit Loss
ProfitLoss
-6736737 USD
CY2013 us-gaap Profit Loss
ProfitLoss
-26153158 USD
CY2012 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-1456 USD
CY2013 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
0 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-6735281 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-26153158 USD
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.60
CY2012 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30419556 shares
CY2013 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43635182 shares
CY2012Q3 xxii Warrants Issued To Purchase Common Stock
WarrantsIssuedToPurchaseCommonStock
371000 shares
CY2012Q4 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights
1.00
CY2013 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2013Q1 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2012Q2 xxii Class Of Warrant Or Right Expiration Period
ClassOfWarrantOrRightExpirationPeriod
P5Y
CY2013Q4 xxii Common Stock Additional Conversion Price
CommonStockAdditionalConversionPrice
4166666 shares
xxii Exercise Of Warrants Upon Conversion Of Equity On Cashless Basis
ExerciseOfWarrantsUponConversionOfEquityOnCashlessBasis
1160080 shares
CY2013 xxii Exercise Of Warrants Upon Conversion Of Equity On Cashless Basis
ExerciseOfWarrantsUponConversionOfEquityOnCashlessBasis
1160080 shares
CY2013 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
555165 USD
CY2013 xxii Warrant Liabilities Fair Value
WarrantLiabilitiesFairValue
1445091 USD
xxii Exercise Of Warrants For Cash
ExerciseOfWarrantsForCash
275000 shares
CY2013 xxii Exercise Of Warrants For Cash
ExerciseOfWarrantsForCash
275000 shares
CY2013Q3 xxii Cashless Exercise Warrant Shares
CashlessExerciseWarrantShares
416668 shares
CY2011 us-gaap Interest Expense Debt
InterestExpenseDebt
17386 USD
CY2013 us-gaap Interest Expense Debt
InterestExpenseDebt
17386 USD
CY2012Q4 xxii Number Of Warrants Issued During Period
NumberOfWarrantsIssuedDuringPeriod
1619000 shares
CY2012Q4 xxii Estimated Fairvalue Of Warrants
EstimatedFairvalueOfWarrants
353747 USD
CY2011Q4 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
550000 USD
CY2012 xxii Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
1183543 USD
CY2013 xxii Change In Fair Value Of Warrant Liabilities
ChangeInFairValueOfWarrantLiabilities
19271977 USD
CY2011Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
8668701 shares
CY2012Q4 xxii Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
3523033 shares
CY2013Q4 xxii Class Of Warrant Or Right Issued
ClassOfWarrantOrRightIssued
11570274 shares
CY2012 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
780930 shares
CY2013 xxii Common Stock Warrants Issued Additional Number
CommonStockWarrantsIssuedAdditionalNumber
1665400 shares
CY2012 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
0 shares
CY2013 xxii Number Of Warrants Exercised
NumberOfWarrantsExercised
-9831414 shares
CY2013 us-gaap Payments To Acquire Businesses Gross
PaymentsToAcquireBusinessesGross
200000 USD
CY2013 us-gaap Business Combination Consideration Transferred Equity Interests Issued And Issuable
BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable
800000 USD
CY2012Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
12972664 shares
CY2013Q4 us-gaap Defined Benefit Plan Funded Percentage
DefinedBenefitPlanFundedPercentage
0.03 pure
CY2013 us-gaap Defined Benefit Plan Contributions By Employer
DefinedBenefitPlanContributionsByEmployer
34873 USD
CY2013 xxii Milestone Payment
MilestonePayment
150000 USD
CY2012 xxii Patent Initiative Expenses
PatentInitiativeExpenses
104558 USD
CY2013 xxii Patent Initiative Expenses
PatentInitiativeExpenses
101902 USD
CY2013Q4 xxii Annual License Fee
AnnualLicenseFee
75000 USD
CY2013 xxii Lease Term
LeaseTerm
P3Y
CY2013 us-gaap Business Combination Consideration Transferred1
BusinessCombinationConsiderationTransferred1
1000000 USD
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due Current
CapitalLeasesFutureMinimumPaymentsDueCurrent
96000 USD
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Two Years
CapitalLeasesFutureMinimumPaymentsDueInTwoYears
123000 USD
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Three Years
CapitalLeasesFutureMinimumPaymentsDueInThreeYears
298275 USD
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Four Years
CapitalLeasesFutureMinimumPaymentsDueInFourYears
338250 USD
CY2013Q4 us-gaap Capital Leases Future Minimum Payments Due In Five Years
CapitalLeasesFutureMinimumPaymentsDueInFiveYears
338250 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
45000 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
10000 USD
CY2012 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2013 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
0 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30419556 shares
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
43635182 shares
CY2012 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.22
CY2013 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.60
CY2012 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.22
CY2013 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.60
CY2012 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
19436446 shares
CY2013 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
11813469 shares
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
100000 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.56
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.68
CY2011 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
242160 USD
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
186959 USD
CY2012 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0171 pure
CY2013 us-gaap Fair Value Assumptions Risk Free Interest Rate
FairValueAssumptionsRiskFreeInterestRate
0.0189 pure
CY2012 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Fair Value Assumptions Expected Dividend Rate
FairValueAssumptionsExpectedDividendRate
0 pure
CY2012 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2013 us-gaap Fair Value Assumptions Expected Volatility Rate
FairValueAssumptionsExpectedVolatilityRate
0.9 pure
CY2012 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
CY2013 us-gaap Fair Value Assumptions Expected Term
FairValueAssumptionsExpectedTerm
P10Y
CY2011Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1212160 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2013 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2013 xxii Stock Issued During Period Warrants Excercised Value
StockIssuedDuringPeriodWarrantsExcercisedValue
14097594 USD
CY2012 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
722209 USD
CY2013 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
2361962 USD
CY2013 xxii Other Contributed Capital
OtherContributedCapital
1660 USD
CY2013 us-gaap Dividends Common Stock Stock
DividendsCommonStockStock
0 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
35000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
455000 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
215000 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
465000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
660000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
660000 shares
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.20
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.65
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.80
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.69
CY2013Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
923500 USD
CY2012 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
18173 USD
CY2013 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
4232 USD
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1372018 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
134296 USD
CY2012 xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
31350 USD
CY2013 xxii Non Cash Interest On Convertible Debt
NonCashInterestOnConvertibleDebt
526448 USD
CY2012 xxii Derivative Gains Losses Net
DerivativeGainsLossesNet
-1998043 USD
CY2013 xxii Derivative Gains Losses Net
DerivativeGainsLossesNet
-23602711 USD
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
807675 USD
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
980162 USD
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
416496 USD
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.74
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
0.74
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P8Y7M6D
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P8Y7M6D
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
923500 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
1381800 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
552403 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
175754 USD
CY2012 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-7630 USD
CY2013 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-10044 USD
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
705415 USD
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-629101 USD
CY2012 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-2470 USD
CY2013 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-3567 USD
CY2012 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-58041 USD
CY2013 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
118105 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1764445 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3855834 USD
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
162774 USD
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
290336 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-162774 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3742789 USD
CY2012 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
56000 USD
CY2013 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 USD
CY2012 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
41000 USD
CY2013 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1620299 USD
CY2012 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
0 USD
CY2013 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
339250 USD
CY2012 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1467500 USD
CY2013 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
210000 USD
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
0 USD
CY2012 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
0 USD
CY2013 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
2034664 USD
CY2012 xxii Proceeds Exercise Of Warrants
ProceedsExerciseOfWarrants
0 USD
CY2013 xxii Proceeds Exercise Of Warrants
ProceedsExerciseOfWarrants
-2254999 USD
CY2012 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
0 USD
CY2013 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
1660 USD
CY2012 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
21478 USD
CY2013 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
5100 USD
CY2012 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
4136 USD
CY2013 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-3893 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
1675158 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5717366 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-252061 USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
5830411 USD
CY2011Q4 us-gaap Cash
Cash
252249 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
5200 USD
CY2012 xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
0 USD
CY2013 xxii Conversion Of Accrued Interest To Note Payable
ConversionOfAccruedInterestToNotePayable
26422 USD
CY2012 xxii Deferred Private Placement Costs Charged To Contributed Capital
DeferredPrivatePlacementCostsChargedToContributedCapital
4526 USD
CY2012 us-gaap Interest Paid Net
InterestPaidNet
15317 USD
CY2013 us-gaap Interest Paid Net
InterestPaidNet
135247 USD
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
CY2012 xxii Issuance Of Common Stock In Exchange For Account Payable
IssuanceOfCommonStockInExchangeForAccountPayable
-359754 USD
CY2013 xxii Issuance Of Common Stock In Exchange For Account Payable
IssuanceOfCommonStockInExchangeForAccountPayable
0 USD
CY2012 xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
0 USD
CY2013 xxii Conversion Of Accounts Payable To Note Payable
ConversionOfAccountsPayableToNotePayable
769377 USD
CY2012 xxii Supplemental Accounts Payable
SupplementalAccountsPayable
359754 USD
CY2013 xxii Supplemental Accounts Payable
SupplementalAccountsPayable
769377 USD
CY2013 xxii Deferred Private Placement Costs Charged To Contributed Capital
DeferredPrivatePlacementCostsChargedToContributedCapital
0 USD
CY2012 xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
120750 USD
CY2013 xxii Conversion Of Notes Payable And Accrued Interest To Common Stock
ConversionOfNotesPayableAndAccruedInterestToCommonStock
1650305 USD
CY2012 xxii Increase Decrease In Original Issue Disount On Convertible Debt
IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt
12600 USD
CY2013 xxii Increase Decrease In Original Issue Disount On Convertible Debt
IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt
0 USD
CY2012 xxii Increase Decrease In Beneficial Conversion Feature
IncreaseDecreaseInBeneficialConversionFeature
116600 USD
CY2013 xxii Increase Decrease In Beneficial Conversion Feature
IncreaseDecreaseInBeneficialConversionFeature
0 USD
CY2012 xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
0 USD
CY2013 xxii Dividend Payable On Preferred Stock
DividendPayableOnPreferredStock
93361 USD
CY2012 xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
0 USD
CY2013 xxii Refinance Of Note Payable To Accounts Payable
RefinanceOfNotePayableToAccountsPayable
57500 USD
CY2012 xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
1532347 USD
CY2013 xxii Issuance Of Warrants As Derivative Liability Instrument
IssuanceOfWarrantsAsDerivativeLiabilityInstrument
5675634 USD
CY2012 xxii Increase In Warrant Liability And Reduction In Capital Due Changes In Exercise Price Of Warrant
IncreaseInWarrantLiabilityAndReductionInCapitalDueChangesInExercisePriceOfWarrant
0 USD
CY2013 xxii Increase In Warrant Liability And Reduction In Capital Due Changes In Exercise Price Of Warrant
IncreaseInWarrantLiabilityAndReductionInCapitalDueChangesInExercisePriceOfWarrant
626328 USD
CY2012 xxii Issuance Of Warrants As Derivative Liability Instruments
IssuanceOfWarrantsAsDerivativeLiabilityInstruments
92750 USD
CY2013 xxii Issuance Of Warrants As Derivative Liability Instruments
IssuanceOfWarrantsAsDerivativeLiabilityInstruments
0 USD
CY2012 xxii Reclassification Of Derivative Liability To Equity
ReclassificationOfDerivativeLiabilityToEquity
0 USD
CY2013 xxii Reclassification Of Derivative Liability To Equity
ReclassificationOfDerivativeLiabilityToEquity
14433178 USD
CY2012 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
0 USD
CY2013 xxii Patent And Trademark Additions Included In Accounts Payable
PatentAndTrademarkAdditionsIncludedInAccountsPayable
42490 USD
CY2013 us-gaap Contracts Revenue
ContractsRevenue
807000 USD
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Trading Symbol
TradingSymbol
XXII
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
58252770 shares
CY2013 dei Entity Registrant Name
EntityRegistrantName
22nd Century Group, Inc.
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001347858
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
-4526 USD
CY2012 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
10000 USD
CY2012 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
116600 USD
CY2012 xxii Stock Issued During Period Of Stocks And Warrants For Services Or Claims
StockIssuedDuringPeriodOfStocksAndWarrantsForServicesOrClaims
517753 USD
CY2012 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-30000 USD
CY2012 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
0 USD
CY2013 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
17889 USD
CY2013 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
0 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
0 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
179014 USD
CY2013 xxii Warrant Exchange Inducement Expense
WarrantExchangeInducementExpense
3736313 USD
CY2012 us-gaap Interest Expense Related Party
InterestExpenseRelatedParty
272758 USD
CY2013 us-gaap Interest Expense Other
InterestExpenseOther
730716 USD
CY2012 us-gaap Interest Expense Other
InterestExpenseOther
1221787 USD
CY2013 us-gaap Licenses Revenue
LicensesRevenue
7000000 USD
CY2012 us-gaap Licenses Revenue
LicensesRevenue
0 USD
CY2013 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
278383 USD
CY2012 us-gaap Sales Revenue Goods Gross
SalesRevenueGoodsGross
18775 USD
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
7278383 USD
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
18775 USD
CY2013 us-gaap License Costs
LicenseCosts
413566 USD
CY2012 us-gaap License Costs
LicenseCosts
0 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
48105 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
67967 USD
CY2013 us-gaap Gross Profit
GrossProfit
6816712 USD
CY2012 us-gaap Gross Profit
GrossProfit
-49192 USD
CY2013Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
457696 USD
CY2012Q4 us-gaap Assets Held For Sale Current
AssetsHeldForSaleCurrent
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
2997760 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6030 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
179014 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
0 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5200 USD
CY2013 xxii Stockissued During Period Value Warrant Exchange Program
StockissuedDuringPeriodValueWarrantExchangeProgram
23340847 USD
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
25000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.69
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.26
CY2013 xxii Stock Issued During Period Shares Stock Options Exercised1
StockIssuedDuringPeriodSharesStockOptionsExercised1
20000 shares
CY2013 xxii Income Tax Refund
IncomeTaxRefund
-122024 USD
CY2012 xxii Income Tax Refund
IncomeTaxRefund
0 USD
CY2013 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2012 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2012 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
0 USD
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2012 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.018 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Tax Exempt Income
EffectiveIncomeTaxRateReconciliationTaxExemptIncome
0.020 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.355 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.101 pure
CY2013 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
829306 USD
CY2012 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-1370382 USD
CY2013 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
186414 USD
CY2012 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-308039 USD
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
1015720 USD
CY2012 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-1678421 USD
CY2013 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
-1015720 USD
CY2012 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1678421 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.340 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.005 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.030 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.039 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.249 pure
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.0 pure
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
2616624 USD
CY2012Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
3694817 USD
CY2013Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
21725 USD
CY2012Q4 us-gaap Deferred Tax Assets Derivative Instruments
DeferredTaxAssetsDerivativeInstruments
21725 USD
CY2013Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
19584 USD
CY2012Q4 us-gaap Deferred Tax Assets Inventory
DeferredTaxAssetsInventory
69120 USD
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
131450 USD
CY2012Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
0 USD
CY2013Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
1292 USD
CY2012Q4 us-gaap Deferred Tax Assets Other
DeferredTaxAssetsOther
967 USD
CY2013Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
2790675 USD
CY2012Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
3776629 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
52445 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Deferred Expense Capitalized Inventory Costs
DeferredTaxLiabilitiesDeferredExpenseCapitalizedInventoryCosts
0 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2956 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2333 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
523157 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Goodwill And Intangible Assets Intangible Assets
DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets
490882 USD
CY2013Q4 xxii Deferred Tax Liabilities Stock Based Compensation
DeferredTaxLiabilitiesStockBasedCompensation
0 USD
CY2012Q4 xxii Deferred Tax Liabilities Stock Based Compensation
DeferredTaxLiabilitiesStockBasedCompensation
28300 USD
CY2013Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
0 USD
CY2012Q4 us-gaap Deferred Tax Liabilities Other
DeferredTaxLiabilitiesOther
27277 USD
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
2212117 USD
CY2012Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
3227837 USD
CY2013Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
578558 USD
CY2012Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
548792 USD
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2012Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0 USD
CY2013Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
6800000 USD
CY2013 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
2994757 USD
CY2012 us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
0 USD
CY2013 xxii Net Proceeds From Warrant Exchange Program
NetProceedsFromWarrantExchangeProgram
3239385 USD
CY2012 xxii Net Proceeds From Warrant Exchange Program
NetProceedsFromWarrantExchangeProgram
0 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 USD
CY2013 xxii Property Plant And Equipment Held For Salse
PropertyPlantAndEquipmentHeldForSalse
457696 USD
CY2013 us-gaap Stock Issued During Period Shares Issued For Services
StockIssuedDuringPeriodSharesIssuedForServices
1780000 shares
CY2013 xxii Liabilities Reversed Current
LiabilitiesReversedCurrent
290000 USD
CY2013Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
3220000 USD
CY2013Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
210000 USD
CY2012Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
0 USD
CY2013Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
17059 USD
CY2012Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
9106 USD
CY2013Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
14500 USD
CY2012Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
0 USD
CY2012Q4 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
0 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3003863 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
9106 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
6103 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3076 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
177000 USD
CY2013 xxii Refundable Taxes And Tax Credits
RefundableTaxesAndTaxCredits
122000 USD
CY2013 us-gaap Deferred Revenue Revenue Recognized
DeferredRevenueRevenueRecognized
7000000 USD
CY2012 xxii Refundable Taxes And Tax Credits
RefundableTaxesAndTaxCredits
0 USD
CY2013 xxii Working Capital
WorkingCapital
6759781 USD
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
5830599 USD
CY2013Q4 us-gaap Equity Method Investments
EquityMethodInvestments
7529000 USD
CY2013 xxii Description On Issuance Of Financial Services Obligations
DescriptionOnIssuanceOfFinancialServicesObligations
the Company believes it will have adequate cash reserves to sustain operations and meet all current obligations as they come due for a period in excess of 12 months.
CY2013Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2559412 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
2226586 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1014543 USD
CY2012Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
873282 USD
CY2013Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1544869 USD
CY2012Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
1353304 USD
CY2013 xxii Cost Of Inducement Under Warrant Exchange Program
CostOfInducementUnderWarrantExchangeProgram
3274313 USD
CY2013 xxii Reclassification Of Warrant Liability To Equity Upon Exercise Of Warrants
ReclassificationOfWarrantLiabilityToEquityUponExerciseOfWarrants
-7712170 USD
CY2013 xxii Reclassification Of Warrant Liability To Equity Resulting From Warrant Exchange Program
ReclassificationOfWarrantLiabilityToEquityResultingFromWarrantExchangeProgram
-19639465 USD
CY2013Q2 dei Entity Public Float
EntityPublicFloat
18300000 USD
CY2013 xxii License Agreements Expiration Date
LicenseAgreementsExpirationDate
2022
CY2013 us-gaap Cost Of Revenue
CostOfRevenue
461671 USD
CY2012 us-gaap Cost Of Revenue
CostOfRevenue
67967 USD
CY2013Q4 xxii Property Plant And Equipment Including Assets Held For Sale
PropertyPlantAndEquipmentIncludingAssetsHeldForSale
3461559 USD
CY2012Q4 xxii Property Plant And Equipment Including Assets Held For Sale
PropertyPlantAndEquipmentIncludingAssetsHeldForSale
9106 USD
CY2013 xxii Number Of Warrants Exercised Under Warrant Exchange Program
NumberOfWarrantsExercisedUnderWarrantExchangeProgram
5862121 shares
CY2013 xxii Class Of Warrants Or Rights Issued Under Warrant Exchange Program
ClassOfWarrantsOrRightsIssuedUnderWarrantExchangeProgram
138666 shares
CY2013 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Exchange Program
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantExchangeProgram
19639465 USD
CY2012 xxii Reclassification Of Derivative Liability To Equity Due To Warrant Exchange Program
ReclassificationOfDerivativeLiabilityToEquityDueToWarrantExchangeProgram
0 USD
CY2013 xxii Common Stock Issued For Fees Relating To December2013 Warrant Exchange Program
CommonStockIssuedForFeesRelatingToDecember2013WarrantExchangeProgram
462000 shares
CY2012 xxii Common Stock Issued For Fees Relating To December2013 Warrant Exchange Program
CommonStockIssuedForFeesRelatingToDecember2013WarrantExchangeProgram
0 shares
CY2013 xxii Common Stock Issued For Fees Relating To January2013 Preferred Stock Private Placement
CommonStockIssuedForFeesRelatingToJanuary2013PreferredStockPrivatePlacement
416666 shares
CY2012 xxii Common Stock Issued For Fees Relating To January2013 Preferred Stock Private Placement
CommonStockIssuedForFeesRelatingToJanuary2013PreferredStockPrivatePlacement
0 shares
CY2012 xxii Stock Issued During Period Value New Issues Two
StockIssuedDuringPeriodValueNewIssuesTwo
455644 USD
CY2013 xxii Warrants With Provision Of Anti Dilution
WarrantsWithProvisionOfAntiDilution
3921381 shares
CY2013 xxii Warrants Without Provision Of Anti Dilution
WarrantsWithoutProvisionOfAntiDilution
6732088 shares
CY2013Q4 us-gaap Deferred Revenue
DeferredRevenue
179014 USD
CY2013 xxii Stock Issues During Period Value Private Placement
StockIssuesDuringPeriodValuePrivatePlacement
0 USD
CY2012 xxii Property Plant And Equipment Held For Salse
PropertyPlantAndEquipmentHeldForSalse
0 USD

Files In Submission

Name View Source Status
0001144204-14-004909-index-headers.html Edgar Link pending
0001144204-14-004909-index.html Edgar Link pending
0001144204-14-004909.txt Edgar Link pending
0001144204-14-004909-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v366195_10k.htm Edgar Link pending
v366195_ex10-12.htm Edgar Link pending
v366195_ex21-1.htm Edgar Link pending
v366195_ex23-1.htm Edgar Link pending
v366195_ex3-2.htm Edgar Link pending
v366195_ex31-1.htm Edgar Link pending
v366195_ex31-2.htm Edgar Link pending
v366195_ex32-1.htm Edgar Link pending
xxii-20131231.xml Edgar Link completed
xxii-20131231.xsd Edgar Link pending
xxii-20131231_cal.xml Edgar Link unprocessable
xxii-20131231_def.xml Edgar Link unprocessable
xxii-20131231_lab.xml Edgar Link unprocessable
xxii-20131231_pre.xml Edgar Link unprocessable